European M&A deals of the month: October 2026

Europe’s biggest mergers and acquisitions in October reflected a market where capital is available for substantial strategic transactions, but the terms of deployment remain demanding. Industrial technology, specialised healthcare, electricity infrastructure, and banking consolidation attracted multi-billion-euro commitments, while contested bids exposed the importance of shareholders, financing, and regulatory approval.

The divergence between transaction value and activity has been building throughout 2026. European M&A value increased 54% in the first nine months compared with the same period last year, according to EY, even as the number of announced transactions declined 11%. Third-quarter activity slowed, with approximately €206.9 billion of M&A recorded across 3,090 transactions, as higher financing costs and valuation disagreements continued to influence dealmaking.

The concentration was also evident in September’s UK M&A market, where buyers committed substantial premiums to specialist engineering, healthcare, communications, and enterprise technology businesses. October’s continental European transactions extended that preference for established capabilities, but added a greater emphasis on industrial software, electrical infrastructure, and the restructuring of major financial institutions.

Private equity remained an important source of capital. Large buyout funds continued to pursue established European businesses with specialist technologies, recurring customer demand, and opportunities for operational development, while strategic acquirers looked to secure expertise and production capacity that could take years to build independently.

The regulatory backdrop is also changing. The European Commission is undertaking its most extensive review of merger guidelines in two decades, examining how transactions affect competition, innovation, investment, and market resilience. Its draft guidance, published in April, is intended to provide a framework better suited to an economy shaped by digitalisation, decarbonisation, and changing global competition.

Five major transactions and takeover developments captured October’s direction. Three were newly agreed acquisitions, while two were existing banking bids that reached significant milestones during the month.

UniCredit advances €45bn Commerzbank takeover —

Italy’s UniCredit moved closer to taking control of Germany’s Commerzbank on 15 October, receiving European Central Bank authorisation to increase its ownership beyond the 30% threshold without an upper limit.

The approval represents a substantial step towards completing the Italian lender’s approximately €45 billion takeover, one of Europe’s largest proposed cross-border banking combinations since the global financial crisis. UniCredit had already concluded the offer’s acceptance period in July, with the shares tendered, its direct holdings, and associated financial instruments giving it potential access to approximately 48% of Commerzbank’s equity.

Once the remaining conditions are satisfied, UniCredit expects to control approximately 50% of Commerzbank’s voting rights. The lender has indicated that this could occur around the end of 2026, although a full operational merger may take considerably longer.

The transaction would bring together UniCredit’s established European banking operations with a German institution deeply embedded in corporate lending, particularly among the country’s Mittelstand businesses. The attraction lies partly in geographic scale and the potential to spread technology, compliance, funding, and operating costs across a larger institution.

The challenge is that Commerzbank’s role extends beyond its balance sheet. Germany’s government has opposed the takeover, while Commerzbank’s leadership continues to favour its independent strategy. Concerns over employment, headquarters, lending relationships, and the treatment of domestic businesses have made the transaction politically sensitive.

The ECB’s authorisation therefore brings UniCredit closer to ownership without resolving the wider questions around integration and stakeholder support. Competition clearance and other outstanding conditions remain part of the process, while management must consider how control of a major German commercial bank can translate into sustainable returns.

Europe’s banking market remains fragmented compared with the United States, and cross-border combinations offer potential economies of scale. UniCredit’s progress shows that major consolidation is possible, although the demands of national banking markets continue to complicate the route from financial control to operational integration.

Intesa’s €31.4bn MPS bid gains ground —

Italian banking consolidation produced an even more intricate contest in October, as Intesa Sanpaolo’s takeover of Banca Monte dei Paschi di Siena advanced following the rejection of a defensive acquisition strategy.

Intesa had launched its unsolicited offer in June, seeking to acquire MPS through a combination of newly issued shares and cash. On 3 October, it improved the terms by raising the cash component from €1 to €1.25 per MPS share, alongside 1.6 newly issued Intesa shares. The revised consideration valued the transaction at approximately €31.4 billion using the reference share price specified by Intesa, although its market value fluctuates with the acquirer’s shares.

The increase formed part of a broader contest over MPS’s direction. Under chief executive Luigi Lovaglio, the Siena-based bank had proposed acquiring Banco BPM and wealth manager Banca Generali, creating a substantially larger institution that would be more difficult for Intesa to absorb.

Those transactions were prominent in August’s European M&A analysis, when MPS sought to alter the terms of its own takeover through two major share-based acquisitions. October brought a decisive shareholder judgement on that strategy.

At an extraordinary meeting on 29 October, shareholders rejected the proposed Banco BPM and Banca Generali acquisitions by overwhelming margins. Approximately 91% of the capital represented voted against the two offers. A separate proposal to merge MPS with Mediobanca, which it already controlled, was also rejected.

The following day, Intesa confirmed that its takeover would proceed. The bank had already obtained ECB authorisation on 27 October, although competition clearance and other conditions remained outstanding.

The scale and complexity of these transactions are unusual even by the standards of European banking consolidation. MPS has spent recent years transforming its business through acquisitions, while Intesa’s proposal would create another substantial reorganisation involving commercial banking, wealth management, and investment banking assets.

October also demonstrated the limits of acquisition-led takeover defence. MPS’s leadership had presented a larger group as an alternative to Intesa’s offer, but the proposed transactions required shareholders to accept substantial additional integration, financing, and execution commitments.

The rejection of those plans strengthened Intesa’s position, while leaving the eventual structure of the combined businesses subject to regulatory review. In a market where scale can deliver meaningful efficiencies, the willingness of shareholders to support the chosen route to consolidation remains decisive.

Schneider Electric pays $23.7bn for PTC —

Industrial technology supplied October’s largest newly agreed European-led acquisition when France’s Schneider Electric announced a definitive agreement to acquire American software company PTC on 5 October.

The all-cash transaction values PTC’s equity at approximately $22.6 billion and implies an enterprise value of $23.7 billion. Schneider agreed to pay $205 per share, representing a 42.3% premium to PTC’s previous closing price.

PTC develops software used across industrial product design, engineering, product lifecycle management, and asset management. Its platforms help manufacturers manage complex products and the associated data from initial development through production, maintenance, and service.

For Schneider, the acquisition brings those capabilities alongside an established business in industrial automation, energy management, and digital infrastructure. Combining product-development systems with operational technology would give the enlarged group a broader role across customers’ engineering and manufacturing activities.

The attraction extends beyond additional software revenue. Manufacturers increasingly need connected information across engineering, factory operations, maintenance, and energy consumption. PTC’s technology could help Schneider develop more integrated services in those areas, supported by AI and automation.

Schneider expects annual cost synergies of approximately €250 million by the third year following completion and has identified around €800 million of potential revenue synergies. Those projections depend on successful integration, commercial execution, and customers adopting the combined offering.

The financial commitment is substantial. Schneider plans to fund the consideration through approximately €5–6 billion of new equity and €16–17 billion of debt, while seeking to preserve its investment-grade credit position.

Investors responded cautiously. Schneider’s shares fell nearly 10% in early trading following the announcement, reflecting concerns about the purchase price, financing requirements, and the outlook for software valuations as AI changes the competitive environment.

The reaction illustrates the distinction between an attractive strategic combination and an acquisition that immediately satisfies shareholders’ return expectations. Schneider is buying capabilities that would be difficult to replicate organically, but the premium creates a demanding financial benchmark for management.

Completion is expected by the third quarter of 2027, subject to shareholder and regulatory approvals. Until then, the transaction represents one of Europe’s most significant commitments to bringing industrial software, automation, and AI capabilities under common ownership.

EQT agrees €10.8bn Qiagen takeover —

Private equity’s continued appetite for European healthcare technology was demonstrated on 21 October when Swedish investment group EQT agreed a recommended cash acquisition of Dutch-headquartered diagnostics company Qiagen.

The transaction values Qiagen at approximately €10.8 billion on an enterprise-value basis. EQT has offered €46.50 per share, a 40.3% premium to the company’s unaffected share price before takeover interest became public in July.

Qiagen develops technologies for processing and analysing biological samples, with products used across molecular diagnostics, clinical testing, pharmaceutical development, and life sciences research. Its position rests on specialised intellectual property, established laboratory workflows, and long-standing relationships with healthcare and research customers.

Those characteristics make Qiagen an attractive candidate for long-term institutional ownership. Its products are embedded in activities where reliability, regulatory compliance, and technical performance are essential, while continued growth requires investment in research, product development, and commercial infrastructure.

EQT is partnering with investors connected to the Abu Dhabi Investment Authority and Canada Pension Plan Investment Board, bringing substantial international institutional capital into the proposed acquisition.

Qiagen’s supervisory and management boards unanimously support the offer following a strategic review that considered independent development and discussions with potential buyers. The proposed ownership structure would allow the business to pursue investment priorities away from the demands of quarterly public-market reporting.

The transaction also demonstrates the scale at which private equity is prepared to operate. Acquiring a business with a multi-billion-euro valuation requires substantial financial resources, sector knowledge, and confidence in the durability of demand.

However, the premium places considerable weight on Qiagen’s ability to generate future growth and returns. The buyer will need to balance investment in new technologies with the financing obligations attached to the transaction.

Completion is expected in mid-2027, subject to regulatory clearances, shareholder acceptance, and other conditions. The offer requires acceptance representing at least 50% of Qiagen’s outstanding shares plus one share.

GE Vernova buys Trench for $9bn —

Europe’s electricity infrastructure attracted another substantial commitment on 28 October, when US energy technology company GE Vernova agreed to acquire German-headquartered Trench Group from investment firm Triton Partners for approximately $9 billion.

Trench develops and manufactures high-voltage electrical components, including instrument transformers, bushings, and coils used in electricity transmission networks. The business employs more than 3,000 people across 11 manufacturing sites in Europe, North America, and Asia.

GE Vernova is acquiring an established supplier with specialist equipment, manufacturing expertise, and relationships with more than 800 utilities and hyperscale customers. Trench also brings approximately $5 billion in backlog and framework agreements, providing visibility over future demand.

The acquisition addresses an increasingly important constraint in the global energy system. Electricity grids require substantial modernisation and expansion to accommodate industrial electrification, renewable generation, and rising data-centre demand. However, high-voltage equipment cannot always be supplied quickly because production depends on specialist engineering, materials, skilled personnel, and qualified manufacturing capacity.

Rather than developing equivalent capabilities entirely within its existing operations, GE Vernova is bringing an established supplier directly into its Electrification business. That should increase the group’s exposure to grid investment while improving its control over selected components and manufacturing capacity.

The price reflects significant expectations. GE Vernova forecasts that Trench will generate approximately $1.9 billion in revenue in 2028, with an adjusted EBITDA margin of around 36%. The transaction is expected to be financed through an equal combination of cash and debt, with completion anticipated in late 2027.

The acquisition also illustrates private equity’s ability to develop industrial assets for subsequent sale to strategic buyers. Under Triton’s ownership, Trench expanded its manufacturing network and developed into a larger international supplier.

Grid infrastructure remains a capital-intensive market where investment commitments extend across many years. Trench’s value lies partly in its production capacity, customer relationships, and existing order commitments, but also in the time required for competitors to establish comparable capabilities.

Further consolidation in pharmaceuticals and chemicals —

Two transactions outside the principal five reinforced the importance of valuation, shareholder support, and industrial restructuring.

In Italy, CVC Capital Partners and Belgium’s Groupe Bruxelles Lambert increased their offer for pharmaceutical company Recordati to €53 per share on 6 October, valuing the business at approximately €11 billion.

By the end of the offer period on 23 October, the consortium had secured approximately 74.3% of Recordati’s capital. That exceeded its minimum acceptance threshold of 66.7%, although it remained below the 90% level required for the intended delisting.

The higher offer followed pressure over the original valuation, demonstrating how the terms of a sizeable takeover can change as shareholders assess the value of surrendering control.

Germany’s chemicals industry offered a contrasting outcome. BASF pursued a potential acquisition of specialist chemicals group Evonik, improving its approach to a reported €11.18 billion, equivalent to €24 per share.

On 30 October, Evonik declined to enter formal negotiations, maintaining its commitment to an independent strategy while leaving room for a confidential exchange with BASF.

The proposed transaction reflected competitive pressures facing European chemicals manufacturers, particularly rising energy costs and international competition. Evonik’s refusal nevertheless underlined that an argument for greater scale does not automatically establish an acceptable acquisition price or a sufficiently compelling strategic case.

What October’s deals say about European M&A —

October extended the concentration of capital already visible across Europe in 2026. Transaction values have increased substantially faster than deal numbers, with the largest commitments directed towards businesses possessing established technology, specialist infrastructure, market positions, or operating capabilities that are difficult to reproduce.

Industrial businesses featured prominently, but the economic rationale varied. Schneider is seeking to connect engineering software with its industrial technology portfolio, while GE Vernova is buying manufacturing capacity and specialist electrical equipment. Both acquisitions address gaps that could be filled organically only through substantial investment and years of development.

Healthcare demonstrated a different form of strategic value. Qiagen and Recordati attract capital through specialised products, established customers, and demand linked to long-term medical and research requirements. Their transactions also show that private ownership continues to appeal where investment horizons, portfolio development, and public-market valuations do not align comfortably.

Banking supplied the month’s most visible regulatory and governance complexity. UniCredit’s progress towards control of Commerzbank and Intesa’s stronger position over MPS both demonstrate the potential for substantial consolidation, but neither transaction can be assessed through valuation alone.

National economic priorities, competition concerns, shareholder decisions, and the integration of existing businesses all influence the eventual outcome. In October, those factors directly affected the direction of two of Europe’s most substantial banking transactions.

The European Commission’s review of merger guidelines adds another dimension. The draft framework examines the relationship between competition, investment, innovation, and resilience at a time when European industry is seeking greater scale to compete internationally. Its eventual application will influence how some of the region’s largest combinations are evaluated.

Financial discipline remains equally important. Schneider’s immediate market reaction illustrated the scrutiny attached to substantial acquisition premiums, while the increased Recordati offer and Evonik’s refusal to negotiate demonstrated the continued importance of price in securing agreement.

October’s sentiment was therefore constructive without being indiscriminate. Capital remains available for acquisitions with a credible industrial or financial rationale, but execution certainty, financing capacity, and shareholder alignment are increasingly prominent in determining whether those transactions proceed.

October’s European M&A activity leaves the market entering the final months of 2026 with substantial strategic ambitions but continued selectivity. Buyers are committing capital to industrial technology, specialist healthcare, energy infrastructure, and financial consolidation, while target boards and shareholders remain focused on valuation and execution certainty.

The largest transactions demonstrate where conviction has concentrated: established businesses with capabilities, market positions, and infrastructure that could take years to recreate. Whether those commitments translate into successful combinations will depend on financing, regulatory approvals, shareholder support, and the ability to deliver the operating improvements underpinning the acquisition price.